Global Stock News

Assessing uniQure (QURE) After Sharp Share Price Slide And Gene Therapy Regulatory Focus

Assessing uniQure (QURE) After Sharp Share Price Slide And Gene Therapy Regulatory Focus

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.

  • If you are wondering whether uniQure’s current share price reflects its true worth, you are not alone. This article walks through what the numbers are really saying about the stock.

  • The share price is at US$15.63, with returns of a 33.3% decline over 7 days, a 31.2% decline over 30 days and a 33.2% decline year to date, while the 1 year return sits at 18.9% and the 3 and 5 year returns at 26.2% and 51.9% declines respectively.

  • Recent news around uniQure has focused on ongoing interest in gene therapy, regulatory developments and how smaller biotech names are being reassessed by investors….

Source link

Share this article

Scroll to Top